07.01.2014 Views

LIFE01200604005 Shri Somnath Ghosh - Homi Bhabha National ...

LIFE01200604005 Shri Somnath Ghosh - Homi Bhabha National ...

LIFE01200604005 Shri Somnath Ghosh - Homi Bhabha National ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CHAPTER 1<br />

INTRODUCTION<br />

associates with chromatin specifically during S-phase and it is thought that it plays a<br />

functional role during normal replication [32, 33]. Transient inhibition of ATR results in<br />

(i) inappropriate firing of replication origins [34]; (ii) fork stalling and (iii) replication<br />

induced chromosome breakage [35, 36]. Recently, some individuals with the Seckel<br />

syndrome were found to have very low levels of ATR kinase in their cells due to a splice<br />

mutation in the ATR gene [37]. These individuals share phenotypes with DNA damage<br />

response syndromes such as the Nijmegen breakage syndrome<br />

Since the intrinsic kinase activity of ATR does not change appreciably following DNA<br />

damage, it is thought that ATR activity is primarily regulated through its cellular<br />

localization. ATR is known to form distinct nuclear foci following blockage of<br />

replication [38] and it has been shown that the single strand-binding protein RPA and the<br />

ATR-interacting protein ATRIP are important for the recruitment of ATR to sites of<br />

blocked replication forks [26, 27]. It is thought that stretches of single-stranded DNA are<br />

formed in and around the stalled replication fork and that these sequences become coated<br />

with RPA proteins. ATR/ATRIP is then recruited to the site of RPA-coated DNA where<br />

ATR phosphorylates its substrates. Some studies have shown that ATR is capable of<br />

phosphorylating its targets even in cells depleted of RPA suggesting that in some<br />

situation RPA may not be required for ATR activity [39, 40].<br />

The Nijmegen breakage syndrome (NBS) has overlapping phenotypes with both ataxia<br />

telangiectasia (AT) and the ATR-Seckel syndrome [37, 41]. Following treatment with the<br />

replication blocking agent hydroxyurea (HU), Chk1 kinase and the tumor suppressor p53<br />

are phosphorylated in an ATR-dependent manner and cells that make it through S-phase<br />

will arrest in the G2 phase of the cell cycle [41]. In NBS1-defective cells, however, the<br />

39

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!